Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Hiro

30results about How to "Maintain affinity" patented technology

Method used for producing humanized antibodies or antigen combination fragments

The invention discloses a method used for producing humanized antibodies or antigen combination fragments. The method comprises following steps: antibody heavy chain variable region and light chain variable region sequences of a non-human organism specific to a certain antigen are obtained; the sequences are compared with amino acid sequences of human embryonal system antibodies; human embryonal system amino acid sequences, which possesses highest homology with the heavy chain variable region and the light chain variable region of the non-human organism, are selectively respectively; human embryonal system antibody heavy chain and light chain variable region frame libraries are constructed, and a complete frame assembly library is assembled; the frame assembly library is expressed so as to obtain humanized heavy chain variable region and light chain variable region, which are capable of combining with the antigen, by screening, and realize preparation of the humanized antibodies or the antigen combination fragments of the humanized heavy chain variable region and light chain variable region. The method is capable of avoiding dependence on antibody structure analysis in antibody engineering processes, at the same, realizing screening on antibody expression and stability, and maintaining affinity of the humanized antibodies as far as possible.
Owner:NANJING LEGEND BIOTECH CO LTD

A method of producing a humanized antibody or antigen-binding fragment

The invention discloses a method used for producing humanized antibodies or antigen combination fragments. The method comprises following steps: antibody heavy chain variable region and light chain variable region sequences of a non-human organism specific to a certain antigen are obtained; the sequences are compared with amino acid sequences of human embryonal system antibodies; human embryonal system amino acid sequences, which possesses highest homology with the heavy chain variable region and the light chain variable region of the non-human organism, are selectively respectively; human embryonal system antibody heavy chain and light chain variable region frame libraries are constructed, and a complete frame assembly library is assembled; the frame assembly library is expressed so as to obtain humanized heavy chain variable region and light chain variable region, which are capable of combining with the antigen, by screening, and realize preparation of the humanized antibodies or the antigen combination fragments of the humanized heavy chain variable region and light chain variable region. The method is capable of avoiding dependence on antibody structure analysis in antibody engineering processes, at the same, realizing screening on antibody expression and stability, and maintaining affinity of the humanized antibodies as far as possible.
Owner:NANJING LEGEND BIOTECH CO LTD

Oral nanoparticles for penetrating gastrointestinal mucus and epithelial cell barriers and preparation method and application of oral nanoparticles

ActiveCN111346233APositively electroadhesiveTypical hydrophobic secondary core space structurePeptide/protein ingredientsMetabolism disorderPolythylene glycolStearic acid
The invention discloses a preparation method of oral nanoparticles for penetrating gastrointestinal mucus and epithelial cell barriers. The method comprises the following steps: (1) preparing a pH response material: connecting polyethylene glycol to stearic acid through an acylhydrazone bond to obtain the pH response material; (2) preparing a polymer material: connecting chitosan oligosaccharide to stearic acid through an amido bond to obtain the polymer material; and (3) preparing the nanoparticles: mixing the pH response material in the step (1) to the polymer material in the step (2), and performing nano coprecipitation self-assembly to obtain the core-shell oral nanoparticles taking the polymer material as an inner core and the pH response material as an outer shell. According to the nanoparticles prepared by the preparation method provided by the invention, in a mucus microenvironment, the acylhydrazone bond is broken and falls off from a polyethylene glycol shell, and a CSO-SA core is exposed, so that conversion from hydrophilicity to hydrophobicity, conversion from near-neutrality to positive charges and increase of adhesion of the surface of the nanoparticles are realized,the epithelial cell barrier spanning capability of the nanoparticles is enhanced, and the oral absorption rate of drugs is increased.
Owner:ZHENGZHOU UNIV

An oral nanoparticle for penetrating gastrointestinal mucus and epithelial cell barrier and its preparation method and application

The invention discloses a preparation method of oral nanoparticles for penetrating gastrointestinal mucus and epithelial cell barrier, comprising the following steps: (1) preparing a pH-responsive material: combining polyethylene glycol and stearic acid through an acylhydrazone bond Connect to obtain a pH-responsive material; (2) prepare a polymer material: connect the chitosan oligosaccharide and stearic acid through an amide bond to obtain a polymer material; (3) prepare a nanoparticle: combine the pH-responsive material of the above step (1). It is mixed with the polymer material of step (2), and a nano-coprecipitation self-assembly method is adopted to obtain a core / shell oral nanoparticle with the polymer material as the core and the pH-responsive material as the shell. In the nanoparticles obtained by the preparation method provided by the invention, the acylhydrazone bonds are broken and the polyethylene glycol shell is broken off in the mucus microenvironment, and the CSO-SA inner core is exposed, so as to realize the transition from hydrophilicity to hydrophobicity and near neutrality to positive charge on the surface of the nanoparticles Transition and increased adhesion, which in turn enhances its ability to cross the epithelial cell barrier, improve the oral absorption rate of the drug.
Owner:ZHENGZHOU UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products